Children’s Hospital Boston
Boston, Massachusetts, United States
Purpose
to develop a 4-valent Shigella vaccine using Multi-Antigen Presentation System technology to a stage where it would be ready for production for a human clinical study
Division
Global Health
Date
October 2021
Region Served
GLOBAL
Committed amount
$2,617,853
Grant topic
Enterics, Diagnostics, Genomics & Epidemiology
Duration (months)
56
Grantee location
Boston, Massachusetts, United States
More about our financials
Our story
Learn about the origins of the foundation and the values that drive our work.
Our work
Learn about where we work around the globe and the programs we’ve created to address urgent issues in global health, global development, and education.
How we work
We are focused on results. Those that can be measured. And those measured in ways beyond numbers.